Low-dose IL-2 to the Kinetics of Regulatory T-cell in Healthy Volunteers

NCT03837093 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: ILT101
DRUG: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]